Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HCW Biologics (HCWB) Shares Outstanding (2020 - 2025)

HCW Biologics (HCWB) has disclosed Shares Outstanding for 6 consecutive years, with $2.6 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Shares Outstanding rose 177.25% year-over-year to $2.6 million, compared with a TTM value of $2.6 million through Sep 2025, up 177.25%, and an annual FY2024 reading of $1.1 million, down 96.91% over the prior year.
  • Shares Outstanding was $2.6 million for Q3 2025 at HCW Biologics, up from $2.1 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $35.9 million in Q3 2023 and bottomed at $900628.0 in Q4 2023.
  • Average Shares Outstanding over 5 years is $18.1 million, with a median of $5.4 million recorded in 2021.
  • The sharpest move saw Shares Outstanding soared 652.97% in 2021, then tumbled 97.49% in 2023.
  • Year by year, Shares Outstanding stood at $35.8 million in 2021, then rose by 0.3% to $35.9 million in 2022, then crashed by 97.49% to $900628.0 in 2023, then grew by 23.64% to $1.1 million in 2024, then surged by 135.43% to $2.6 million in 2025.
  • Business Quant data shows Shares Outstanding for HCWB at $2.6 million in Q3 2025, $2.1 million in Q2 2025, and $1.1 million in Q1 2025.